Detalles de la búsqueda
1.
Patient preferences in the treatment of stage III/IV classic Hodgkin lymphoma: Results from the CONNECT cross-sectional survey.
Br J Haematol
; 204(4): 1262-1270, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38323849
2.
Physician frontline treatment preferences for stage III/IV classic Hodgkin lymphoma: the real-world US CONNECT study.
Future Oncol
; 20(12): 749-760, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37665273
3.
Retrospective Analysis With Propensity Score Matching of Peripheral T-Cell Lymphoma Treated Frontline With Brentuximab Vedotin and Chemotherapy.
Oncologist
; 28(6): 520-530, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36971492
4.
The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey.
Support Care Cancer
; 31(12): 664, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914825
5.
Real-World Treatment Patterns and Clinical Outcomes With Brentuximab Vedotin or Other Standard Therapies in Patients With Previously Treated Cutaneous T-Cell Lymphoma in the United States.
Clin Lymphoma Myeloma Leuk
; 24(2): e21-e32.e4, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37919137
6.
Brentuximab Vedotin Retreatment in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma or Peripheral T-Cell Lymphoma: A Retrospective United States Claims Analysis.
Curr Oncol
; 31(5): 2598-2609, 2024 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38785476
7.
Real-World Use of Positron Emission Tomography-Computed Tomography and Reported Deauville Scores in Advanced-Stage Classic Hodgkin Lymphoma: A Community Oncology Practice Perspective.
JCO Oncol Pract
; 19(10): 860-870, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37651672
8.
Cost-Effectiveness of Brentuximab Vedotin Versus Physician's Choice of Methotrexate or Bexarotene for the Treatment of Cutaneous T-cell Lymphoma in Canada.
Adv Ther
; 40(5): 2326-2338, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36920744
9.
Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Stage III or IV Classic Hodgkin Lymphoma Treated With Frontline ABVD: A Retrospective Database Review in the United States.
Clin Lymphoma Myeloma Leuk
; 23(7): 527-534, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37121857
10.
Estimating long-term progression-free and overall survival in patients with peripheral T-cell lymphoma: A US population-based oncology simulation model based on 5-year results from the ECHELON-2 trial.
J Manag Care Spec Pharm
; 29(3): 314-323, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36840956
11.
Estimating long-term outcomes in classic Hodgkin lymphoma: a United States population-based oncology simulation model based on overall survival from the ECHELON-1 trial.
Leuk Lymphoma
; 64(5): 1017-1025, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37074674
12.
Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography-Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT Study.
JCO Oncol Pract
; 19(6): e867-e876, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36947720
13.
Cost-effectiveness of brentuximab vedotin plus chemotherapy for previously untreated CD30-positive peripheral T-cell lymphoma in Canada.
J Med Econ
; 25(1): 324-333, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172685
Resultados
1 -
13
de 13
1
Próxima >
>>